Dobson, R, Craner, M, Waddingham, E, Miller, A, Pindoria, J, Cavey, A, Blain, C, De, LG, Evangelou, N, Ford, H, Gallagher, P, George, K, Geraldes, RDR, Harman, P
, Hobart, J, King, T, Linighan, R, MacDougall, N, Marta, M, Mitchell, S, Nicholas, R, Rog, D, Scalfari, A, Scolding, N, Webb, S, White, S, Wilton, J, Young, C & Matthews, PM 2022, '
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)',
Multiple Sclerosis and Related Disorders, vol. 63, no. 0.
https://doi.org/10.1016/j.msard.2022.103894